Trump FY 2020 Budget Renews Push To Reform 180-Day Exclusivity
US FDA would get an overall increase in funding under the president's fiscal year 2020 budget proposal, although the generic drug industry opposes reforms targeting the 180-day exclusivity clock for first filers.
You may also be interested in...
The idea could help quiet growing criticism over system gaming and high drug prices.
Asked during Senate hearing whether the 351(k) pathway would be repealed along with the rest of the ACA under a pending lawsuit, the outgoing commissioner acknowledged that it would, but said he hoped Congress would create it again.
AAM's Chip Davis said a user fee cut is not in order, but industry consolidation and product launch problems may mean it cannot accept another large increase.